SOPHiA GENETICS
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Boston, Massachusetts, United States, North America
Region: Massachusetts
Country: US
Continent: North America
About
SOPHiA GENETICS delivers data-driven medicine for precision oncology and rare disorders by providing an AI- and cloud-powered platform that analyzes diverse health data to generate real-time, actionable insights. The company operates globally, enabling clinicians, providers, and biopharma partners to accelerate diagnosis, treatment decisions, and research through multi-omics data analytics, including genomics, radiomics, and multimodal data. It emphasizes data governance and privacy while helping healthcare institutions translate complex datasets into actionable patient care across oncology and hereditary diseases.
SOPHiA GENETICS provides an AI-powered cloud platform that analyzes multi-omics data to support precision medicine in oncology and rare disorders. The company serves healthcare providers, hospitals, and biopharma partners by generating actionable insights from genomic and radiomic data. Its technology facilitates faster diagnosis and treatment decisions while maintaining strict data governance and
SOPHiA GENETICS SA.
2011
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Public Company
534799999
50m-100m
private
NASDAQ:SOPH
nasdaq
Investors
Founders
Jurgi Camblong
Lars Steinmetz
Pierre Hutter
Leadership
Jurgi Camblong — Founder and CEO
Manuela Valente — SVP, Chief People Officer
Lara Hashimoto — Chief Business Officer
Zhenyu Xu — Chief Scientific Officer
Ken Freedman — Chief Revenue Officer
Daan Van Well — Chief Legal Officer | General Counsel
Philippe Menu — EVP, Chief Product Officer and Chief Medical Officer
Antoine Duchateau — board_member
Michael Schenck — board_member
Technology Stack
Products
SOPHiA DDM™ Platform: A cloud-based AI platform that analyzes complex healthcare data to provide actionable insights for precision medicine in oncology and inherited disorders.
SOPHiA DDM™ for Genomics: A module of the SOPHiA DDM™ Platform focused on analyzing genomic data for oncology, blood cancers, hereditary cancers, liquid biopsy, and rare inherited disorders.
SOPHiA DDM™ for Radiomics: A module that extracts and analyzes quantitative data from medical imaging to provide novel insights in oncology research and clinical practice.
SOPHiA DDM™ for Multimodal: A platform module that integrates and harmonizes genomic, imaging, clinical, and biological data to generate novel insights and predictive models in oncology research.
Alamut™ Visual Plus: A software tool for detailed variant annotation and interpretation to support genetic analysis in research and clinical settings.
OncoPortal™: An add-on module providing advanced visualization and interpretation tools for oncology genomic data within the SOPHiA DDM™ Platform.
